KRAS and neoplasm: Researches disclosed that when the carcinogenic KRAS signaling pathway is activated, it promotes inhibitory cytokines and chemokines secretion in alveolar cells, thus affecting the recruitment and polarization of various immune cells, shaping the inhibitory TME, which is conducive to the tumor development42.